CYTK R&D to Revenue
Cytokinetics Inc · R&D to Revenue
CYTK R&D to Revenue
Latest reported306.47%period ending
CYTK Quarterly R&D/Revenue (282.14% → 306.47%)
Latest values, visible window
High-resolution chart · PNG
CYTK r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 306.4705% | |
| 493.5417% | |
| 571.8783% | |
| 5,125.6715% | |
| 168.5722% | |
| 6,323.0526% | |
| 553.134% | |
| 18,274.73% | |
| 31,966.6667% | |
| 9,768.8623% | |
| 5,082.2967% | |
| 21,833.8624% | |
| 9,595.6171% | |
| 1,721.6779% | |
| 3,833.3163% | |
| 2,494.3936% | |
| 64.2096% | |
| 4,001.3066% | |
| 78.2338% | |
| 890.8589% | |
| 1,281.8502% | |
| 481.9945% | |
| 434.7069% | |
| 58.0551% | |
| 606.457% | |
| 568.3137% | |
| 351.7652% | |
| 334.0875% | |
| 336.5139% | |
| 278.1782% | |
| 248.235% | |
| 201.0243% | |
| 347.2566% | |
| 420.1784% | |
| -145,838.8889% | |
| 403.6731% | |
| 648.8372% | |
| 464.4594% | |
| 56.66% | |
| 30.2556% | |
| 167.5801% | |
| 160.7173% | |
| 135.7897% | |
| 145.4626% | |
| 193.1519% | |
| 202.8999% | |
| 40.3484% | |
| 121.2958% | |
| 150.7062% | |
| 156.5359% | |
| 56.7744% | |
| 300.8503% | |
| 1,223.6868% | |
| 1,197.8076% | |
| 451.3736% | |
| 513.3022% | |
| 447.6915% | |
| 480.4945% | |
| 1,135.9313% | |
| 623.0554% | |
| 998.3856% | |
| 1,203.0144% | |
| 833.576% | |
| 2,423.0964% | |
| 2,215.5844% | |
| 1,460.2254% | |
| 960.1173% | |
| 179.0229% | |
| 14.1832% | |
| 323.5543% | |
| 363.8959% | |
| 432.608% | |
| 483.3767% | |
| 459.4982% | |
| 448.8103% | |
| 320.0242% | |
| 432.0428% | |
| 389.5788% | |
| 8,403.871% | |
| 11,825.4717% | |
| 857.3306% | |
| 793.3803% | |
| 500.6996% | |
| 499.1375% | |
| 428.8338% | |
| 409.6812% | |
| 504.9865% | |
| 389.3426% | |
| 336.1724% | |
| 159.5364% | |
| 0% | |
| 0% | |
| 285.278% | |
| 282.139% |